Original Research
Published on 16 Feb 2023
BRCA1 interactors, RAD50 and BRIP1, as prognostic markers for triple-negative breast cancer severity
in Cancer Genetics and Oncogenomics
- 6,759 views
- 14 citations
Original Research
Published on 16 Feb 2023
in Cancer Genetics and Oncogenomics
Review
Published on 16 Feb 2023
in Cancer Genetics and Oncogenomics
Original Research
Published on 14 Feb 2023
in Cancer Genetics and Oncogenomics
Original Research
Published on 13 Feb 2023
in Cancer Genetics and Oncogenomics
Original Research
Published on 13 Feb 2023
in Cancer Genetics and Oncogenomics
Original Research
Published on 13 Feb 2023
in Cancer Genetics and Oncogenomics
Editorial
Published on 10 Feb 2023
in Cancer Genetics and Oncogenomics
Original Research
Published on 10 Feb 2023
in Cancer Genetics and Oncogenomics
Original Research
Published on 10 Feb 2023
in Cancer Genetics and Oncogenomics
Original Research
Published on 10 Feb 2023
in Cancer Genetics and Oncogenomics
Original Research
Published on 10 Feb 2023
in Cancer Genetics and Oncogenomics
Original Research
Published on 09 Feb 2023
in Cancer Genetics and Oncogenomics
Original Research
Published on 09 Feb 2023
in Cancer Genetics and Oncogenomics
Original Research
Published on 07 Feb 2023
in Cancer Genetics and Oncogenomics
Original Research
Published on 03 Feb 2023
in Cancer Genetics and Oncogenomics
Original Research
Published on 03 Feb 2023
in Cancer Genetics and Oncogenomics
Original Research
Published on 03 Feb 2023
in Cancer Genetics and Oncogenomics
Original Research
Published on 02 Feb 2023
in Cancer Genetics and Oncogenomics
Original Research
Published on 02 Feb 2023
in Cancer Genetics and Oncogenomics
Original Research
Published on 01 Feb 2023
in Cancer Genetics and Oncogenomics
Original Research
Published on 01 Feb 2023
in Cancer Genetics and Oncogenomics
Original Research
Published on 27 Jan 2023
in Cancer Genetics and Oncogenomics
Original Research
Published on 26 Jan 2023
in Cancer Genetics and Oncogenomics
Original Research
Published on 26 Jan 2023
in Cancer Genetics and Oncogenomics